Surrogate Markers and Clinical Outcomes-Reply

Joshua D Wallach¹, Reshma Ramachandran², Joseph S Ross^{2

3}

Affiliations

¹ Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
² Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
³ Deputy Editor, JAMA.

Comment

Joshua D Wallach et al. JAMA. 2024.

. 2024 Sep 17;332(11):936-937.

doi: 10.1001/jama.2024.14279.

Joshua D Wallach¹, Reshma Ramachandran², Joseph S Ross^{2

3}

¹ Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
² Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
³ Deputy Editor, JAMA.

No abstract available

Comment on

Surrogate Markers and Clinical Outcomes.
Siegel J, Thanh Hai M, Stein P. Siegel J, et al. JAMA. 2024 Sep 17;332(11):934-935. doi: 10.1001/jama.2024.14276. JAMA. 2024. PMID: 39167380 No abstract available.
Surrogate Markers and Clinical Outcomes.
Richette P, Dalbeth N, Stamp LK. Richette P, et al. JAMA. 2024 Sep 17;332(11):935-936. doi: 10.1001/jama.2024.14273. JAMA. 2024. PMID: 39167387 No abstract available.